Clinical trial for Pulmonary Arterial Hypertension (PAH)
Official title AIRDROP: Can we Improve Adherence to Inhaled Treatment for Pulmonary Arterial Hypertension?
ClinicalTrials.gov ID: NCT07457762
What this study is testing
- What it's testing
- The study wants to see whether a pharmacist’s guidance can increase how well patients stick to their inhaled iloprost treatment, reduce side effects, and improve health measures.
- Who it's for
- Adults diagnosed with pulmonary arterial hypertension who are prescribed inhaled iloprost.
- What's involved
- Participants will meet with a pharmacist who checks their inhaler technique, advises on managing side effects, and provides follow‑up support, along with routine study visits and tests.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- "Adult patients aged ≥ 18 years, treated at the referral center for PH management at the Heart Institute of the University of São Paulo Medical...
You likely can't join if
- Patients who are unable to perform the 6-minute walk test (6MWT) or who have experienced gastrointestinal bleeding within the 12 weeks prior to the...
The study team makes the final eligibility decision.
Where it is enrolling
- São Paulo, São Paulo, Brazil
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at São Paulo, São Paulo, Brazil. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.